Healthcare Professionals


Mobile Cardiac Telemetry System


At Medtronic, we focus our growth in areas where we can deliver meaningful innovation and value for patients. In line with this commitment, we have decided to concentrate on the Reveal LINQTM Insertable Cardiac Monitor (ICM) System and will discontinue marketing SEEQTM MCT. Medtronic is dedicated to supporting customers through this change. 

SEEQ MCT Prescriptions Accepted through May 25, 2018

We will continue to service patients who currently are using SEEQ MCT, and you may place online orders for new SEEQ patient prescriptions through May 25, 2018. This timeline will enable us to provide monitoring and related services for the duration of the prescriptions. 

Patient Data & Reports Available Online through August 31, 2018

SEEQ MCT patient data and reports will be available to download via SEEQ Online Reporting through August 31, 2018. Beyond this date, Medtronic will be able to pull and send SEEQ MCT patient reports by customer request. 

pdf SEEQ Online Reporting Guide  (.pdf)

This SEEQ Online Reporting Guide provides instructions to view, sort, and download your SEEQ MCT patient data and reports.



Cardiac monitoring and diagnostics play a significant role in the management of heart patients. Medtronic has led in this important market for many years, and we are committed to an even greater level of involvement in monitoring and diagnostics technologies, focusing on Reveal LINQ ICM.

Please contact your Medtronic Diagnostics sales representative with any questions.  


Short-term Cardiac Monitoring Up to 30 Days*

The SEEQ MCT system is ideal for patients experiencing frequent symptoms that require short-term monitoring.

SEEQ MCT Patient Satisfaction

Rated excellent in patient satisfaction,1 our patient-friendly design and proactive support services help drive patient compliance.2


The Medtronic SEEQ Mobile Cardiac Telemetry (MCT) System is intended to continuously measure, record and periodically transmit physiological data. The System is indicated for those patients who require monitoring for the detection of non-lethal cardiac arrhythmias such as, but not limited to supraventricular tachycardias (e.g. atrial fibrillation, atrial flutter, paroxysmal SVTs), ventricular ectopy, bradyarrhythmias and conduction disorders. The SEEQ MCT System monitors, derives and displays: ECG, Heart Rate.


SEEQ Wearable Sensor

  • Wire-free, slim-profile sensor
  • 7.5-day sensor duration, no battery changes required
  • Up to 30 days of monitoring with multiple sensors
  • Water-resistant, may be worn while showering
  • Auto trigger and patient trigger

SEEQ Transmitter

SEEQ Transmitter
  • Bluetooth® connection to wearable sensor with up to 30-foot range
  • Continuous monitoring via cellular network
    • Automatic episode transmission
    • 12-hour battery use before recharging

Medtronic Monitoring Center

Medtronic Monitoring Center Image
  • Certified Independent Diagnostic Testing Facility (IDTF)
  • Certified cardiographic technicians and customer support representatives
  • 24/7 review of incoming ECG data and report generation

Online Reporting with Clinic Dashboard

SEEQ MCT Online Reports
  • 24/7 clinic-wide visibility to prescription status, patient data, and reports
  • End-of-use Summary Report
  • Episode Report
  • Reports also available by email or fax


Access prescriber and other manuals on the Medtronic Manual Library. Search by the product name (SEEQ). You may also call 800-961-9055 for a copy of a manual.


Reference the SEEQ MCT Instructions for Use that describes the parameters.

The SEEQ MCT system and the Medtronic Monitoring Center are provided by Medtronic Monitoring Inc., a wholly owned subsidiary of Medtronic.


Engel, et al. Estimation of patient compliance in application of adherent mobile cardiac telemetry device. Presented at 33rd Annual International Conference of the IEEE EMBS, Boston, Massachusetts USA, August 30 - September 3, 2011.


Shinbane, et al. Wearable Wireless Arrhythmia Detection Patches: Diagnostic Arrhythmia Yield, Time to First Arrhythmia, and Patient Compliance. Presented at HRS 2013 (Poster #9813).